Use of evolocumab in refractory coronary artery disease with elevated lipoprotein(a): a case report
Elevated lipoprotein(a) [Lp(a)] is a well-known yet often underrecognized risk factor for atherosclerotic cardiovascular disease and recurrent coronary events. Here, we present the case of a 71-year-old man with multiple cardiovascular comorbidities, including type 2 diabetes mellitus, systemic hype...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| Col·lecció: | MGM Journal of Medical Sciences |
| Matèries: | |
| Accés en línia: | https://doi.org/10.4103/mgmj.mgmj_268_25 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|